A Manatt team, led by Venture Capital and Emerging Companies Partners Richard G.J. McDerby and Michel C. Narganes, along with Corporate and Finance Associate Adriana M. Bass, represented Ennov SAS in their acquisition of the U.S.-based Enterprise Technology division of Calyx, as part of an international team of advisors. Calyx is a provider of clinical research and regulatory solutions. Ennov's acquisition of Calyx’s Enterprise Technology division supports their goal to provide a comprehensive, reliable and affordable cloud-based compliance platform for the life sciences industry. This includes quality, regulatory, pharmacovigilance, clinical and transparency management. With the Enterprise Technology acquisition, Ennov will now offer more efficient, compliant and innovative solutions for life sciences companies of all sizes.
The Manatt Team included partners Sharon B. Bauman, John J. Heber and Andrew Zimmitti.
Ennov offers a software platform for life sciences companies to manage complex processes in a compliant and efficient manner. With more than 20 years of experience, their cloud-based solutions cover regulatory affairs, pharmacovigilance, quality, clinical and document management. Used by over 500 companies and more than 150,000 users globally, Ennov's solutions promote faster product launches while maintaining regulatory compliance.
To learn more about the deal, click here.